We are live on ! Find out more
AF

Amalgamated Financial Portfolio holdings

AUM $12.6B
This Fund
S&P 500
This Quarter Est. Return
-2.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.6B
AUM Growth
Cap. Flow
+$12.4B
Cap. Flow %
98.67%
Top 10 Hldgs %
24.33%
Holding
3,002
New
2,999
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$709M
2
MSFT icon
Microsoft
MSFT
+$617M
3
AMZN icon
Amazon
AMZN
+$371M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$223M
5
TSLA icon
Tesla
TSLA
+$208M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 13.15%
3 Healthcare 13.05%
4 Consumer Discretionary 12.17%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTM icon
2526
Verastem
VSTM
$592M
$40K ﹤0.01%
+2,346
New +$40.4K
NPKI
2527
NPK International
NPKI
$1.14B
$40K ﹤0.01%
+10,921
New +$40.6K
CINC
2528
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$40K ﹤0.01%
+2,271
New +$46.6K
ATRO icon
2529
Astronics
ATRO
$3.84B
$39K ﹤0.01%
+3,619
New +$39.4K
BLUE
2530
DELISTED
bluebird bio
BLUE
$39K ﹤0.01%
+407
New +$53.7K
PRCT icon
2531
Procept Biorobotics
PRCT
$1.17B
$39K ﹤0.01%
+1,124
New +$27K
UTMD icon
2532
Utah Medical Products
UTMD
$225M
$39K ﹤0.01%
+433
New +$39.8K
DICE
2533
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$39K ﹤0.01%
+2,029
New +$36.2K
LUNA
2534
DELISTED
Luna Innovations Incorporated
LUNA
$39K ﹤0.01%
+5,040
New +$36.2K
FHTX icon
2535
Foghorn Therapeutics
FHTX
$360M
$38K ﹤0.01%
+2,501
New +$34.3K
FNLC icon
2536
First Bancorp
FNLC
$399M
$38K ﹤0.01%
+1,252
New +$39.1K
HBIO icon
2537
Harvard Bioscience
HBIO
$29.2M
$38K ﹤0.01%
+620
New +$36.7K
MELI icon
2538
Mercado Libre
MELI
$92.3B
$38K ﹤0.01%
+32
New +$34.8K
MLR icon
2539
Miller Industries
MLR
$619M
$38K ﹤0.01%
+1,367
New +$42.1K
RUSHB icon
2540
Rush Enterprises Class B
RUSHB
$6.14B
$38K ﹤0.01%
+1,175
New +$39K
SSTI icon
2541
SoundThinking
SSTI
$103M
$38K ﹤0.01%
+1,385
New +$37.7K
VTGN icon
2542
VistaGen Therapeutics
VTGN
$12.8M
$38K ﹤0.01%
+1,012
New +$44.1K
FMTX
2543
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$38K ﹤0.01%
+4,107
New +$43.7K
COGT icon
2544
Cogent Biosciences
COGT
$7.24B
$37K ﹤0.01%
+4,942
New +$34.4K
CTRN icon
2545
Citi Trends
CTRN
$605M
$37K ﹤0.01%
+1,199
New +$56K
CVGI icon
2546
Commercial Vehicle Group
CVGI
$147M
$37K ﹤0.01%
+4,377
New +$35.4K
HBCP icon
2547
Home Bancorp
HBCP
$566M
$37K ﹤0.01%
+905
New +$36.9K
HOV icon
2548
Hovnanian Enterprises
HOV
$807M
$37K ﹤0.01%
+626
New +$56.6K
LFCR icon
2549
Lifecore Biomedical
LFCR
$190M
$37K ﹤0.01%
+3,163
New +$35.2K
OPRT icon
2550
Oportun Financial
OPRT
$372M
$37K ﹤0.01%
+2,558
New +$42.7K

Similar funds

Amalgamated Financial's Q1 2022 Portfolio in Review

Q1 2022 is the first quarter with a 13F filing on record for Amalgamated Financial, which disclosed 3,002 positions worth $12.6B. Its ten largest holdings account for 24% of the portfolio.

Its largest position is Apple: 4,217,665 shares worth $736M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, followed by Financials and Healthcare.

  • Amalgamated Financial's largest Q1 2022 buy was Apple: 4,217,665 shares worth $736M.
  • Amalgamated Financial's ten largest holdings make up 24% of its $12.6B portfolio in Q1 2022.
  • Amalgamated Financial disclosed 3,002 positions in Q1 2022, its first 13F filing on record.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.